Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Interventions
DRUG

activated recombinant human factor VII

Trial Locations (37)

1756

Novo Nordisk Investigational Site, Sofia

2193

Novo Nordisk Investigational Site, Johannesburg

11042

Novo Nordisk Investigational Site, New Hyde Park

19104

Novo Nordisk Investigational Site, Philadelphia

28046

Novo Nordisk Investigational Site, Madrid

35100

Novo Nordisk Investigational Site, Bornova-IZMIR

Novo Nordisk Investigational Site, Capa-ISTANBUL

39008

Novo Nordisk Investigational Site, Santander

41013

Novo Nordisk Investigational Site, Seville

46260

Novo Nordisk Investigational Site, Indianapolis

48201

Novo Nordisk Investigational Site, Detroit

52242

Novo Nordisk Investigational Site, Iowa City

59037

Novo Nordisk Investigational Site, Lille

60612

Novo Nordisk Investigational Site, Chicago

75015

Novo Nordisk Investigational Site, Paris

77030

Novo Nordisk Investigational Site, Houston

90027

Novo Nordisk Investigational Site, Los Angeles

94270

Novo Nordisk Investigational Site, Le Kremlin-Bicêtre

94704

Novo Nordisk Investigational Site, Berkeley

105077

Novo Nordisk Investigational Site, Moscow

300011

Novo Nordisk Investigational Site, Timișoara

13081970

Novo Nordisk Investigational Site, Campinas

70112-2699

Novo Nordisk Investigational Site, New Orleans

02115

Novo Nordisk Investigational Site, Boston

07112

Novo Nordisk Investigational Site, Newark

19134-1095

Novo Nordisk Investigational Site, Philadelphia

C1425ASU

Novo Nordisk Investigational Site, Ciudad Autónoma de Bs. As.

20211-030

Novo Nordisk Investigational Site, Rio de Janeiro

10130-110

Novo Nordisk Investigational Site, Belo Horizonte

52011-000

Novo Nordisk Investigational Site, Recife

14051-140

Novo Nordisk Investigational Site, Ribeirão Preto

Unknown

Novo Nordisk Investigational Site, Manila

80-952

Novo Nordisk Investigational Site, Gdansk

20-954

Novo Nordisk Investigational Site, Lublin

00-576

Novo Nordisk Investigational Site, Warsaw

00-791

Novo Nordisk Investigational Site, Warsaw

022328

Novo Nordisk Investigational Site, Bucharest

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY